A new study reported at the European Digestive Disease Week (UEG) shows that regardless of family history, colorectal cancer screening has doubled since the age of 45 rather than 50. (UEG 2017)
In investigatores advertendum quod de communi hominum colonoscopy protegendo progressio suadet L protegendo pro populo per annos, sed per annos L colorectal cancer incidentiae est auctus.
Hoc studium futurum aestimari (VI)XXVII casibus a colonoscopy. Et tremorum rates of polyps, Adenomas, polyps magna et cancer erant 6027%, 34.0%, 32.0% quod 8.0%, respective. Inventa ex hoc studium est, quod unus magis cum periculo adenoma deprehensionem cancer tractatores intendunt astruere quod a diversis aetatis coetus et populos sub deprehendatur rate de XXX annorum valde humilis et factum est relative humilis in conspectu XLV annos natus. Illic est a valde significant incremento.
Alioqui brutum habeatur deprehendatur rate de mediocris de XXXV% super (IV)CDXXXVIII aegris super L annorum esset et deprehensionem cancer rate est V% exceditur. Polypi deprehendatur rate de mediocris etatis 4438-50 annorum erat XXVI% DXV aegris et deprehensionem cancer rate est fere IV%. De rebus deprehendatur rate of MLXXVI ≤35 annorum erat humilis. Exclusa etiam, post a familia historia de summus periculo populatio: deprehensionem cancer rate est etiam princeps in medio populi vel aetatis XLV, ut polypi XLIX annis.
The researchers believe that the research population is a real practice population, so the research conclusions are applicable to the general screening population. 50-year-old should not be used as the starting age for screening, and colorectal cancer screening should be started from 45-year-old to better prevent colorectal cancer. The results of the study suggest that, even if there is no family history, the risk of disease will increase greatly after the age of 45, which is more critical.
